tirzepatide journal club SURMOUNT-1 Trial Journal Club - Tirzepatide may

ZEPBOUND is contraindicated in patients with a personal or family history of MTC or in patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) [see Contraindications (4)]

Unlike most countries where patent protection extends into the 2030s, Canada found itself in a unique position after key Canadian patent protection lapsed earlier than expected due to a maintenance-fee issue

For all these reasons, lasting reduction in body weight is generally a very difficult goal to achieve for many people, especially when the level of adiposity is high

Protein preserves muscle during weight loss, supports satiety between meals, and provides the amino acid building blocks that your body needs for repair and maintenance